research Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.
Search
for
Sort by
Research
360-390 / 1000+ results 
research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study
COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
research A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
COVID-19 may trigger sudden temporary hair loss.
research Long COVID? What Is That?
Long COVID is a serious, long-lasting illness that needs more recognition and support.
research Long-Term Efficacy and Safety of Baricitinib in Patients With Severe Alopecia Areata: 104-Week Results From BRAVE-AA1 and BRAVE-AA2
Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.
research Abnormal Saccadic Oscillations Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Encephalopathy and Ataxia
A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.
research Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata Over 52 Weeks in Phase III Trials
Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.
research The Necessity of Investigations to Clarify Sex and Racial Disparities in Pathophysiology of Long COVID
More research is needed to understand sex and racial differences in long COVID.
research Characterizing Loss of Response in Patients During Long-Term Maintenance Therapy with Baricitinib: Results From BRAVE-AA1 and AA2 Trials
Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.
research Living With Long COVID and Its Impact on Family and Society: A Couple's View
Long COVID has severely affected a couple's health, finances, and social life.
research Rosella C
Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.
research JAMA Dermatology: The Year in Review, 2021
In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.
research Hair Loss as a Symptom of Many Complex Medical and Psychological Problems
Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.
research Heterogeneous Red-White Discoloration of the Nail Bed and Distal Onycholysis in a Patient with COVID-19
A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.
research Assessment of Selective Elements in Serum and Hair Samples of Women with Post-COVID-19 Alopecia: Copper Significance
Copper deficiency is linked to post-COVID-19 hair loss in women.
research Post-Discharge Persistent Symptoms and Health-Related Quality of Life After Hospitalization for COVID-19
Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.
research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients
COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.
research Androgen Deprivation Therapy May Be a More Effective COVID-19 Prophylactic Than Therapeutic Strategy
Androgen deprivation therapy might be better for preventing COVID-19 than treating it.
research Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.
research The Most Common Pediatric And Adult Dermatology Patient Complaints In A Month Of The COVID-19 Pandemic In Turkey
During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.
research COVID-19 Dermatological Manifestations: Results from the Mexican Academy of Dermatology COVID-19 Registry
COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.
research Capillary Impacts of Covid-19: The Link Between Acute Telogen Effluvium and Alopecia Areata - An Integrative Review
Covid-19 can cause hair loss due to immune and psychological factors.
research Burden of Post-COVID-19 Hair Loss Among Older Adults in Vietnam
Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.
research Change in Dermatology Practice During Crisis and Normalization Periods After the COVID-19 Pandemic and Potential Problems Awaiting Us
The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.
research Telogen Effluvium: A Sequela of COVID-19
COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
research A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.
research COVID-19 Clinical Outcomes and Nationality: Results from a Nationwide Registry in Kuwait
Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.
research The Incidence of Alopecia Areata in a COVID-19 Vaccinated Population: A Single-Center Review
COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.
research Comparison of Dermatology Diagnoses During COVID-19 Period with Previous Year: What Has Changed?
During the COVID-19 pandemic, some skin conditions became more common while others decreased.
research Cutaneous Manifestations of COVID-19
Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.